Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease

Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease - CTQJ230A12001

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48235

Enrollment

3700

Registered

2019-03-08

Start date

2019-04-24

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperlipoproteinemie Hyperlipoproteinemia increased lipoprotein(a)

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent must be obtained prior to participation in the study 2. Male and female * 18 to * 80 years of age 3. Established CVD defined as one of the following: - History of a myocardial infarction (MI) *3 months and *10 years before the study visit - History of ischemic stroke * 3 months and * 10 years before the study visit - Symptomatic PAD (intermitted claudication with ankle-brachial index *0.90 and/or lower limb amputation or re-vascularization due to lower limb ischemia.

Exclusion criteria

Exclusion criteria: Patients currently enrolled in clinical studies with investigational drugs.

Design outcomes

Primary

Measure	Time frame
Proportion of patients with normal and elevated Lp(a) levels in patients with established CVD.	—

Secondary

Measure	Time frame
Lp(a) values general and by region/country LDL-C levels (corrected and uncorrected)	—

Countries

Netherlands

Outcome results